- Managing Director
- Corporate Finance & Restructuring
- T: +1 646 485 0548
- F: +1 212 841 9350
- Three Times Square
- 9th Floor
- New York, NY, 10036
- United States
- T: +1 212 247 1010
- F: +1 212 841 9350
- B.A., Williams College
- M.B.A., Booth School of Business, The University of Chicago
- CFA® Charterholder
- FINRA Series 79 and Series 63
- Corporate Finance
- Investment Banking & Capital Solutions
- Healthcare & Life Sciences
James McLain is a Managing Director at FTI Consulting and is based in New York. He is a member of FTI Capital Advisors, FTI Consulting’s investment banking subsidiary, and the Healthcare practice. Mr. McLain focuses on providing investment banking advisory services to middle market healthcare companies and private equity investors.
Mr. McLain has 18 years of merger and acquisition (“M&A”) and corporate finance experience, and has initiated and completed numerous strategic and financial transactions for healthcare companies. He has advised owners and management teams in a broad range of healthcare subsectors such as behavioral healthcare, specialty physician services, diagnostic labs, dental products and services, health and wellness, payor services and medical products.
Prior to joining FTI Consulting, Mr. McLain was a Managing Director with Coker Capital Advisors, a healthcare investment bank offering mergers and acquisitions, capital raising and other strategic financial advisory services to middle market healthcare companies. Previously, Mr. McLain worked for Brown Brothers Harriman & Co., where he led the M&A Advisory practice for healthcare services companies. Mr. McLain has also held positions in the healthcare investment banking group at Jefferies & Company and the industrials group at Credit Suisse First Boston.
Mr. McLain holds a B.A. from Williams College, where he graduated cum laude with Honors and was a member of the top ten nationally-ranked squash team. Mr. McLain also holds an M.B.A. from the University of Chicago Booth School of Business. He is a CFA charterholder and holds FINRA Series 79 and Series 63 investment banking licenses.